SJÖGREN'S SYNDROME

Clinical trials for SJÖGREN'S SYNDROME explained in plain language.

Never miss a new study

Get alerted when new SJÖGREN'S SYNDROME trials appear

Sign up with your email to follow new studies for SJÖGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 8 Not yet finished but already full! 2 Completed 3 Terminated 1

New Sjögren's drug ASP5502 enters first human tests

Disease control Terminated

This early-stage study tested a new oral drug, ASP5502, for primary Sjögren's syndrome, an autoimmune condition causing dry eyes and mouth. It involved 116 healthy adults and patients to check safety and how the body processes the drug. The study was terminated, but results may g…

Matched conditions: SJÖGREN'S SYNDROME

Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

SJÖGREN'S SYNDROME

Get alerted when new SJÖGREN'S SYNDROME trials appear

New Sjögren's drug ASP5502 enters first human tests